3 in 5 Campaign

Hospital Pharmacy Operations: A CEO’s Guide

August 17, 2026

Hospital pharmacy operations affect drug spend, revenue, readmissions, and regulatory risk, which are all the things a CEO is ultimately accountable for. A hospital pharmacy operations CEO doesn’t need to manage the department directly, but does need enough visibility to understand when performance is dipping and when it’s time to step in.

Why Pharmacy Deserves C-suite Attention

Pharmacy is a department that is easy to hand off but hard to ignore. It’s one of the largest expense categories a hospital can actually control, and one of the most exposed to regulatory risk, price swings, and clinical liability. Most CEOs don’t have the training to evaluate a formulary or a 340B program. Yet, they’re still the responsible party who needs to answer for it when something goes awry.

Hospital pharmacy CEO responsibilities can be simplified to one principle: make sure someone qualified is running the pharmacy, and give that person the authority and data to be accountable.

Financial Performance: Total Cost, Revenue Integrity, 340B Oversight

Pharmacy spend is usually one of a health system’s largest expense lines, though the exact share depends on system size, payer mix, and specialty drug volume. Either way, it’s big enough to warrant a standing executive review, not a once-a-year look. Three numbers matter most: total pharmacy cost as a share of net revenue, drug spend growth versus volume, and 340B program yield.

Getting a handle on these starts with real pharmacy cost management, because without it, a department can look fine clinically while still eating into margin. If your pharmacy team can’t hand you these numbers on request, it isn’t being run at the executive level yet.

Schedule my assessment

Patient Outcomes and Safety

Pharmacy leadership and hospital executive oversight aren’t just finance topics. How well a pharmacy runs, from staffing levels and how orders are verified to how closely pharmacy is looped into care transitions, directly affects patient outcomes, including medication errors, adverse drug events, and avoidable readmissions.

Readmissions, adverse drug events, liability exposure

Medication issues are a frequent source of avoidable readmissions, and a real source of liability for the hospital. A CEO can’t, nor do they need to, review individual orders. However, they should review the regular reporting on adverse drug events and medication-related readmissions, in the same way that cardiac or surgical outcomes are reported. If that data isn’t reaching you today, that’s worth fixing before it turns into an outcomes problem or even worse, a legal one.

Risk Management

Pharmacy also carries its own kind of risk exposure, apart from the rest of clinical operations. Supply continuity, drug pricing programs, and regulatory compliance rules change frequently and more often here than in most other departments.

Drug shortages, supply chain, regulatory exposure

Drug shortages aren’t a rare occurrence anymore. Instead, they’re much more of a constant. How a pharmacy team handles them (substitutions, backup suppliers, keeping clinical staff informed) affects both care and cost. It’s one of several ongoing pharmacy challenges worth checking in on before they turn into bigger problems. On the compliance side, controlled substance programs deserve close attention right now. The DEA has been ramping up audit teams and stepping up the frequency of hospital audits, and lapses here can point to bigger problems like diversion. The fines can also compound quickly, so this is one area where staying ahead of a gap is far cheaper than catching it after the fact.

The Case for Elevating Pharmacy Leadership

There will come a time when a Director of Pharmacy reporting up through operations isn’t enough. Hospital systems will grow to a size that requires a strategic partner accountable for pharmacy’s financial and clinical performance at the enterprise level. That’s what a Chief Pharmacy Officer is for.

Becker’s Hospital Review has covered this transition over the past couple of years¹. In the article, Troy Shirley, VP of Pharmacy at Bronson Healthcare, discusses how pharmacy leaders now need more than just medication safety and expense management. They’re expected to drive revenue growth, quality, and population health. That’s a much bigger job than a department director role typically covers, and it’s why more systems are creating a CPO position to reflect that.

Ask yourself: is your current pharmacy leadership structure reflective of what’s actually at stake, financially and clinically? If the answer is no, it’s probably time to elevate the role- not simply the title but the reporting line, budget, and authority behind it. If you’re unsure what good hospital pharmacy management looks like at your scale? Our pharmacy operations consulting can provide you with an objective review before you make any changes.

Schedule My Assessment

Key Metrics CEOs Should Track

Category	Metric	Why It Matters
Financial	Total pharmacy cost as % of net revenue	Direct margin impact
Clinical	30-day readmission rate	Ties pharmacy to patient outcomes
Compliance	340B / regulatory audit findings	Risk and revenue integrity

Making Pharmacy a C-Suite Priority

The days of simply letting the pharmacy run in the background are gone. Between margin pressure, patient safety, and regulatory risk, it deserves the same executive attention as nursing, revenue cycle, or supply chain. Whether that involves tightening quarterly reporting or hiring a Chief Pharmacy Officer, the first step should be the same: get a clear picture of where your pharmacy stands today.

Schedule my assessment to see where your pharmacy program stands today.

Frequently Asked Questions About Hospital Pharmacy Operations CEO

What percentage of hospital revenue does pharmacy typically represent?

According to the American Hospital Association’s 2026 Costs of Caring Report, drug spending made up 9% of total hospital expenses in 2025 and grew faster than nearly any other cost category ². This is a big enough and fast-moving enough line item to warrant executive-level review.

What’s the difference between a Director of Pharmacy and a Chief Pharmacy Officer?

A Director of Pharmacy typically leads department-level operations, while a Chief Pharmacy Officer operates at the enterprise level, aligning pharmacy strategy with broader financial and system goals.

How often should hospital leadership review pharmacy performance data?

Quarterly reviews are a common baseline, though systems with active 340B programs or recent compliance findings may benefit from more frequent check-ins.